Moderna
Company www.modernatx.com ● Covered in 4 stories + Follow ✴ AI Graph
Moderna is a company focused on developing mRNA medicines, described on its U.S. website as “pioneering mRNA technology.” Its self-described mission is to deliver impact to people through mRNA medicines, including treatments that prompt the immune system to create tools to treat or prevent disease. Moderna states it has a platform enabling rapid design, research, and testing of multiple mRNAs within days, and it describes its production methods as supporting faster delivery to more people. The official site also presents measures such as “13+ years of progress,” “45 development programs,” and “36 ongoing clinical trials,” alongside an outline that its mRNA medicines contain no animal products or preservatives.
Updated 9 September 2026
Public sources: Official website
Signals
2 stories (+100%)
Media momentum
As of 17 Sep 2026 · Visible stories in the last 30 days, compared with the 30 days before.
4 sources
Source diversity
As of 17 Sep 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 17 Sep 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 17 Sep 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Dec 2025 → Aug 2026
Coverage span
As of 17 Sep 2026 · First to most recent month of TLDRocket coverage of this entity.
Latest developments
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
Ars Technica · 4 weeks ago ·
46
A Unified OS for Drug Development: Our Investment in Cheiron
Menlo Ventures · 1 month ago ·
48
One in a million: celebrating the customers shaping AI’s future
OpenAI · 8 months ago ·
49
August 2026
- 😺 The ACTUAL ChatGPT 3 moment for robotics (one-shot learning)
- mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
July 2026
December 2025
Relationships
Partnerships
- Partnered with Merck · 2 sources
- Partnered with OpenAI · 1 source
- Merck partnered with this company · 1 source
Products & technology
- Integrated with OpenAI · 1 source
- Integrated with Gen-1.5 · 1 source
- Develops Personalized mRNA cancer vaccine · 1 source
- Develops mRNA cancer vaccine · 1 source
- Integrated with Keytruda · 1 source
People
- Robert Langer founded by this company · 1 source